Immune Response to Small Nuclear Ribonucleoprotein Autoantigens
Immune Response to Small Nuclear Ribonucleoprotein Autoantigens
批准号:
8133135
负责人:
ERIC L GREIDINGER
金额:
$30.64万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-01 至 2013-06-30
关键词:
Adoptive TransferAffectAfrican AmericanAntigensApoptosisAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityCD4 Positive T LymphocytesCell LineCell surfaceCellsChimeric ProteinsChronicClinical ResearchClone CellsConnective Tissue DiseasesDevelopmentDiseaseEmployee StrikesEpitopesExhibitsExperimental Animal ModelExposure toFlareGoalsHispanicsHumanImmuneImmune ToleranceImmune responseImmunityInjuryInterstitial Lung DiseasesLinkLungLung diseasesMediatingMixed Connective Tissue DiseaseModelingMolecularMorbidity - disease rateMusNatural HistoryPathogenesisPathogenicityPatientsPhenotypePlayPopulationPrevalenceRNARNA Recognition MotifRNP antigenReactionResearchResearch DesignResearch PersonnelRibonucleoproteinsRoleSm antigenSmall Nuclear RibonucleoproteinsSpecificitySystemic Lupus ErythematosusT-Cell Receptor GenesT-LymphocyteTestingTissuesU1 Small Nuclear RibonucleoproteinWomanWorkbasecomparativecytokineeffective therapymortalityperipheral bloodpolypeptideprogramssynthetic peptide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The focus of our research is on understanding how the immune response to small nuclear ribonucleoprotein (snRNP) self-antigens contributes to disease pathogenesis in Systemic Lupus Erythematosus (SLE) and Mixed Connective Tissue Disease (MCTD). These are chronic, currently incurable diseases that typically affect women, have significant morbidity/mortality and appear increased in prevalence among both Hispanics and African-Americans. Immunity to snRNP autoantigens, including the Smith (Sm) and the U1-70RD polypeptide of the ribonucleoprotein (RNP) antigen, appears to have a central role in these diseases. We have previously isolated and studied Sm-reactive and U1-70kD-reactive T cells from the peripheral blood of SLE and MCTD patients and have begun to characterize the role of murine CD4+ T cells specific for U1- 70kD autoantigen in a new model of MCTD. The hypotheses that these studies are designed to test are: that immune exposure to a fragment of an snRNP, U1-70kD, normally generated during apoptosis and containing an RNA binding domain (RBD), is sufficient to break immunologic tolerance and induce autoreactive CD4+ T cells; and further, that a clonotypically restricted population of U1-70kD autoantigen reactive CD4+ T cells play a central role in autoimmune tissue injury including injury to the lungs. To test these hypotheses, we have proposed the following Specific Aims: 1) characterize a new murine model of sytemic autoimmunity that develops T immunity to the U1-70kD as well as lung disease directly linked to immunity to U1-70kD, 2) identify the cells essential for the development of autoimmune disease in the model using adoptive transfer, 3) define the natural history of interstitial lung disease and identify factors that mediate pulmonary tissue injury in the model, 4) perform a comparative analysis on a distinct subpopulation of T cells that are expanded in the peripheral blood of MCTD patients during active disease. We posit that these will exhibit cell surface phenotype, autoantigen reactivity, epitope fine specificity, T cell receptor (TCR) gene use, effector function and cytokine expression similar to anti-U1-70kD reactive human T cell clones and activated murine T cell lines from the U1-70kD induced model. Lay summary: Systemic Lupus Erythematosus and Mixed Connective Tissue Disease are currently chronic, incurable disease that strike young women, especially black and Hispanic women. Our research goal is to develop new and effective treatments of these disorders.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1177/0961203316655212
发表时间:
2017-02
期刊:
Lupus
影响因子:
2.6
作者:
[Mesa A, Fernandez M, Wu W, Narasimhan G, Greidinger EL, Mills DK]
通讯作者:
Mills DK
T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
T 细胞与干燥综合征和系统性红斑狼疮中免疫耐受的丧失。
DOI:
10.1002/art.22984
发表时间:
2007
期刊:
Arthritis and rheumatism
影响因子:
--
作者:
[Hoffman,RobertW]
通讯作者:
Hoffman,RobertW
DOI:
10.1177/0961203315575586
发表时间:
2015-09
期刊:
Lupus
影响因子:
2.6
作者:
[Carpintero MF, Martinez L, Fernandez I, Romero AC, Mejia C, Zang YJ, Hoffman RW, Greidinger EL]
通讯作者:
Greidinger EL
Analysis of T cell receptors specific for U1-70kD small nuclear ribonucleoprotein autoantigen: the alpha chain complementarity determining region three is highly conserved among connective tissue disease patients.
U1-70kD小核核糖核蛋白自身抗原特异性T细胞受体分析:α链互补决定区3在结缔组织病患者中高度保守。
DOI:
10.1016/s0198-8859(98)00117-7
发表时间:
1999
期刊:
Human immunology
影响因子:
2.7
作者:
[Talken,BL, Lee,DR, Caldwell,CW, Quinn,TP, Schäfermeyer,KR, Hoffman,RW]
通讯作者:
Hoffman,RW
Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease.
干燥症状和抗 SSA/Ro 抗体在混合性结缔组织病中很常见。
DOI:
--
发表时间:
2002
期刊:
The Journal of rheumatology.
影响因子:
--
作者:
[Setty,YatishN, Pittman,CoryB, Mahale,AditS, Greidinger,EricL, Hoffman,RobertW]
通讯作者:
Hoffman,RobertW
共 9 条
Innate Immune Response Patterns to Autoantigen-Associated RNA
-
批准号:8762237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ERIC L GREIDINGER
-
依托单位:
Innate Immune Response Patterns to Autoantigen-Associated RNA
-
批准号:8997924
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ERIC L GREIDINGER
-
依托单位:
Innate Immune Response Patterns to Autoantigen-Associated RNA
-
批准号:8542022
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ERIC L GREIDINGER
-
依托单位:
APOPTOSIS-MODIFIED SELF ANTIGEN IN RHEUMATIC DISEASE
-
批准号:6167091
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2000
-
负责人:ERIC L GREIDINGER
-
依托单位:
APOPTOSIS-MODIFIED SELF ANTIGEN IN RHEUMATIC DISEASE
-
批准号:6532643
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2000
-
负责人:ERIC L GREIDINGER
-
依托单位:
APOPTOSIS-MODIFIED SELF ANTIGEN IN RHEUMATIC DISEASE
-
批准号:6372725
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2000
-
负责人:ERIC L GREIDINGER
-
依托单位:
Immune Response to Small Nuclear Ribonucleoprotein Autoantigens
-
批准号:7878084
-
项目类别:
-
资助金额:$31.91万
-
财政年份:1997
-
负责人:ERIC L GREIDINGER
-
依托单位:
Immune Response to Small Nuclear Ribonucleoprotein Autoantigens
-
批准号:7643291
-
项目类别:
-
资助金额:$32.24万
-
财政年份:1997
-
负责人:ERIC L GREIDINGER
-
依托单位:
海外基金